日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults

鲁拉西酮对急性精神分裂症患者特有的抗敌意作用：青少年和成人汇总事后分析结果

期刊:International Clinical Psychopharmacology
影响因子:2.5
doi:10.1097/YIC.0000000000000563
Citrome, Leslie; Álvarez-Barón, Elena; Gabarda-Inat, Irene; Thangavelu, Karthinathan; Tocco, Michael
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences

探讨精神分裂症及其药物治疗对健康相关生活质量和治疗偏好的影响

期刊:Patient Preference and Adherence
影响因子:2
doi:10.2147/PPA.S494721
Arango, Celso; Baeza, Inmaculada; García-Rizo, Clemente; Crespo-Facorro, Benedicto; Lahera, Guillermo; Vieta, Eduard; Becker, Frauke; Dwyer, Georges; Bourke, Siobhan; Gibson, Adam E J; Gabarda-Inat, Irene; Alvarez-Baron, Elena
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence

鲁拉西酮在西班牙的用途和剂量：RETROLUR，一项基于人工智能的真实世界回顾性分析

期刊:Frontiers in Psychiatry
影响因子:3.2
doi:10.3389/fpsyt.2024.1506142
Mora, Fernando; Gómez Sánchez-Lafuente, Carlos; De Iceta, Mariano; Roset, Carolina; Cárdenas, Antonio; Pérez, Daniel; Álvarez-Barón, Elena; Gabarda-Inat, Irene
RET
发表日期：2024
文献求助 收藏

Lurasidone for the treatment of schizophrenia in adult and paediatric populations

鲁拉西酮用于治疗成人和儿童精神分裂症

期刊:Drugs in Context
影响因子:2.8
doi:10.7573/dic.2022-10-1
Guilera, Teresa; Chart Pascual, Juan Pablo; Blasco, Maria Del Carmen; Calvo Estopiñán, Pilar; Piernas González, Rubén Asensio; Ramírez Martínez, Isabel; Rodríguez Moyano, Cristóbal; Prieto Pérez, Rita; Gabarda-Inat, Irene; Prados-Ojeda, Juan L; Diaz-Marsà, Marina; Martín-Carrasco, Manuel
精神分裂症
神经科学
发表日期：2023
文献求助 收藏